PortViewPortView
Teleflex logo

Teleflex (TFX) Stock Analysis

NYSEHealthcareMedical - Instruments & Supplies

$143.31+2.01%
1-year price historyRange $100.34 – $143.21
52-week range$143.31
$100.18$145.00

What Teleflex does

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Key metrics

Market cap
$6.34B
P/E (TTM)
16.38
EPS (TTM)
$8.75
Beta
0.81
Dividend yield
0.95%
Revenue / share
$59.70
50-day avg
$134.36
200-day avg
$122.64
52-week high
$145.00
52-week low
$100.18
CEO
Jason Weidman

ETFs linked to TFX

Broad-market and Healthcare sector ETFs an investor holding Teleflex is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TFX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TFX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Teleflex?
Teleflex trades under the ticker TFX on NYSE.
Which exchange is TFX listed on?
TFX is listed on NYSE.
What sector does Teleflex operate in?
Teleflex is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze TFX in a portfolio?
PortView shows TFX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.